Fragment-based drug discovery (FBDD) has emerged as a transformative approach in medicinal chemistry by focusing on the identification of small chemical fragments that bind to biologically relevant ...
Fragment-based drug design (FBDD) has led to a revolution in contemporary drug discovery, facilitating a bottom-up approach to the identification and evolution of bioactive small molecules into viable ...
Evotec AG has announced that it has enhanced its Fragment-Based Drug Discovery business through the acquisition of selected assets from Combinature Biopharm. Evotec has acquired equipment and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results